Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2009 | 10-2008 | 07-2008 | 04-2008 | 01-2008 | |
| Sales | 29 | 104 | 0 | 238 | 531 |
| Cost of Goods | 482 | 679 | N/A | 540 | 955 |
| Gross Profit | -453 | -575 | N/A | -302 | -425 |
| Operating Expenses | 961 | 1,472 | 0 | 1,249 | 1,748 |
| Operating Income | -932 | -1,368 | N/A | -1,011 | -1,218 |
| Other Income | 0 | 400 | 0 | 0 | -81 |
| Pre-tax Income | -932 | -968 | 0 | -1,011 | -1,299 |
| Net Income Continuous | -932 | -968 | N/A | -1,011 | -1,299 |
| Net Income | $-932 | $-968 | $N/A | $-1,011 | $-1,299 |
| EPS Basic Total Ops | -0.11 | -0.12 | N/A | -0.12 | -0.16 |
| EPS Basic Continuous Ops | -0.11 | -0.12 | N/A | -0.12 | -0.16 |
| EPS Diluted Total Ops | -0.11 | -0.12 | N/A | -0.12 | -0.16 |
| EPS Diluted Continuous Ops | -0.11 | -0.12 | N/A | -0.12 | -0.16 |
| EBITDA(a) | $-918 | $-1,352 | $N/A | $-973 | $-1,202 |